NCT07416513Recruiting
Digital Solutions for bEtter cAre
ALTHEA: tAckLing menTal Health Cancer Patients and Their Families: Digital Solutions for bEtter cAre
Source: ClinicalTrials.gov · Last updated 18 Feb 2026
Brief summary (registry, in English)
The target population includes cancer patients, caregivers, family members, healthcare providers and mental health specialists, who will be the primary end-users of the Althea platform. For patients, survivors, caregivers, and family members, the sample variables include age, gender, type and stage of disease, and time since the first diagnosis. The healthcare professionals that will be involved in this study are those who attend to oncological patients, with sample variables such as age, gender, professional role, and prior experience and training in oncology or psycho-oncology.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 3 Jun 2025
- Start date
- 14 May 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- European Institute of Oncology
- Diseases
- Childhood cancers
- NCT number
- NCT07416513
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 14 May 2025 to the primary completion date, 31 Dec 2026
- 5 sites in 5 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment, and/or mental disorders that prohibited their participation in the study or inadequate verbal skills that may render them incapable of informed consent (as evaluated by the clinician);
- Physical or psychological impairment that prohibits their participation in focus groups (as evaluated by the clinician).
Other
- Healthcare professionals with limited oncology patient contact;
- Insufficient knowledge of the local language;
- Inability to understand the study materials (as evaluated by the clinician);
Who the study is looking for
- HEALTHCARE PROFESSIONALS:
- Healthcare professionals actually working in oncology and/or psychooncology;
- Teachers of paediatric cancer patients.
- ADULT POPULATION:
- Patients with a current or previous cancer diagnosis
- Adequate language proficiency,
- Able to provide informed consent;
- PAEDIATRIC POPULATION:
- Older than 12 years of age;
- Patients with a current or previous cancer diagnosis;
- Adequate language proficiency;
- Legal guardians of paediatric cancer patients able to provide informed consent.
- CAREGIVERS:
- Caregivers and/or family members of cancer patients who lived or assist the loved ones with a current or previous cancer diagnosis in the cancer journey;
- Adequate language proficiency;
- Able to provide informed consent;
- Caregivers and/or family members of paediatric cancer patients under 12 years of age.
Age in the registry: 12 years to - · Sex: All · Accepts healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Saarland University Coordinator of this site? Confirm its status | Homburg | Germany | Not yet recruiting |
| Catalan Institute of Oncology Coordinator of this site? Confirm its status | Barcelona | Spain | Not yet recruiting |
| Centre François Baclesse Coordinator of this site? Confirm its status | Caen | France | Recruiting |
| European Institute of Oncology Coordinator of this site? Confirm its status | Milan | Italy | Not yet recruiting |
| National Cancer Institute Coordinator of this site? Confirm its status | Vilnius | Lithuania | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.